He told the Financial Times: “Once a new pathogen has demonstrated some degree of human-to-human transmission and some evidence of severity, you have to make a value judgment and do some things at risk because you can’t regain lost time.
“Those first investments are relatively small, several million dollars, and don’t commit you to spending hundreds of millions on day one.”
The UK’s Vaccine Taskforce leader in 2020, Dame Kate Bingham, has said that while the 100-day target is achievable, it “relies on very close international collaboration and leadership to prepare in advance for Disease X”.
Ms Bingham reported directly to the Prime Minister while in charge of the Taskforce during the pandemic, leading a team of world-class experts from across industry, science, academia and Government.
DON’T MISS
Archaeologists making more finds at Rutland Roman villa [REPORT]
Brussels sparks fury as it blocks export of nuclear tech to UK [REVEAL]
UK to bulid new ‘strategic asset’ to end reliance on China [INSIGHT]
Article source: https://www.express.co.uk/news/science/1703484/disease-x-vaccine-taskforce-Coalition-for-Epidemic-Preparedness-Innovations